World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
85
Citations
28571
World Ranking
847
National Ranking
446

Martin McMahon publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Martin McMahon sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 206 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Martin McMahon D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Martin McMahon sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 85 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Martin McMahon is affiliated with the Huntsman Cancer Institute in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these broader fields, they have a significant focus on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine, and Epidemiology.

The scientist's work concentrates on several main topics, including:

  • Melanoma and MAPK Pathways
  • PI3K/AKT/mTOR signaling in cancer
  • Autophagy in Disease and Therapy
  • Ubiquitin and proteasome pathways
  • Ocular Oncology and Treatments
  • Protein Degradation and Inhibitors
  • Advanced Breast Cancer Therapies

The publishing record of Martin McMahon includes multiple articles in prominent venues. Frequent publication venues consist of:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • eLife
  • Oncogene
  • Pigment Cell & Melanoma Research

Some representative recent papers authored by or involving their contributions include:

  • "Melanoma models for the next generation of therapies," 2021, Cancer Cell
  • "Chloroquine Sensitizes GNAQ/11 -mutated Melanoma to MEK1/2 Inhibition," 2020, Clinical Cancer Research
  • "MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition," 2023, The Journal of Experimental Medicine
  • "Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer," 2020, Cell Reports
  • "Autophagy Inhibition in BRAF-Driven Cancers," 2021, Cancers

Frequent co-authors in their publications include:

  • Conan G. Kinsey
  • Michael T. Scherzer
  • Sheri L. Holmen
  • Amanda Truong
  • Gennie L. Parkman

Best Publications

  • Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

    Sarah P. Thayer;Marina Pasca di Magliano;Patrick W. Heiser;Corinne M. Nielsen

  • Differential Activation of ERK and JNK Mitogen-Activated Protein Kinases by Raf-1 and MEKK

    Audrey Minden;Anning Lin;Martin McMahon;Carol Lange-Carter

  • BrafV600E cooperates with Pten loss to induce metastatic melanoma

    David Dankort;David P. Curley;Robert A. Cartlidge;Betsy Nelson

  • Senescence of human fibroblasts induced by oncogenic Raf

    Jiyue Zhu;Douglas Woods;Martin McMahon;J. Michael Bishop

  • Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells

    Richard L. Friedman;Susan P. Manly;Martin McMahon;Ian M. Kerr

  • Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

    Meghna Das Thakur;Fernando Salangsang;Allison S. Landman;William R. Sellers

  • Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

    Matthew Holderfield;Marian M. Deuker;Frank McCormick;Martin McMahon

  • Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.

    Douglas Woods;David Parry;Holly Cherwinski;Elizabeth Bosch

  • A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors

    David Dankort;Elena Filenova;Manuel Collado;Manuel Serrano

  • Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.

    Conan G. Kinsey;Conan G. Kinsey;Soledad A. Camolotto;Amelie M. Boespflug;Amelie M. Boespflug;Katrin P. Guillen

  • The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

    Luping Lin;Amit J Sabnis;Elton Chan;Victor Olivas

  • An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background

    Devarati Mitra;Xi Luo;Ann Morgan;Jin Wang

  • Identification and Characterization of a Constitutively Active STAT5 Mutant That Promotes Cell Proliferation

    Mayumi Onishi;Tetsuya Nosaka;Kazuhide Misawa;Alice L.-F. Mui

  • Opposing Effects of Ras on p53: Transcriptional Activation of mdm2 and Induction of p19ARF

    Stefan Ries;Carola Biederer;Douglas Woods;Ohad Shifman

  • Autophagy Sustains Mitochondrial Glutamine Metabolism and Growth of BRAFV600E-Driven Lung Tumors

    Anne Marie Strohecker;Jessie Yanxiang Guo;Gizem Karsli-Uzunbas;Sandy M. Price

  • Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase.

    M L Samuels;M J Weber;J M Bishop;M McMahon

  • β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas

    William E. Damsky;William E. Damsky;David P. Curley;David P. Curley;Manjula Santhanakrishnan;Lara E. Rosenbaum

  • Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells.

    Kerstin Lehmann;Elzbieta Janda;Christophe E. Pierreux;Marjatta Rytömaa

  • A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma

    Eric A. Collisson;Christy L. Trejo;Jillian M. Silva;Shenda Gu

  • Analysis of the transcriptional program induced by Raf in epithelial cells

    Almut Schulze;Kerstin Lehmann;Harold B. Jefferies;Martin McMahon

Frequent Co-Authors

Marcus Bosenberg
Marcus Bosenberg Yale University
James A. McCubrey
James A. McCubrey East Carolina University
Richard A. Franklin
Richard A. Franklin East Carolina University
Wayne A. Phillips
Wayne A. Phillips Peter MacCallum Cancer Centre
Keith T. Flaherty
Keith T. Flaherty Harvard University
Frank McCormick
Frank McCormick University of California, San Francisco
Alana L. Welm
Alana L. Welm University of Utah
David E. Fisher
David E. Fisher Harvard University
Simon J. Cook
Simon J. Cook Babraham Institute
Jennifer A. Wargo
Jennifer A. Wargo The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology in the USA opens doors to diverse online degree and career options, especially for those interested in health and science fields. Many students with a background in science or nursing consider bridge programs to advance their careers. For example, adn to np programs are ideal for those holding an associate degree in nursing and wanting to become nurse practitioners through a flexible, online route.

If you do not have a nursing background but wish to pivot into advanced nursing, msn direct entry programs online offer an accelerated path. Choosing the right institution is also crucial. Comparing programs like chamberlain vs capella rn to bsn program can help you find the best fit for your learning style and career goals.

For those progressing from a bachelor’s to a master’s in nursing, affordability and flexibility are key. Check out bsn to msn online programs to further specialize while balancing work and study. These pathways can help you align your molecular biology studies with clinical careers in healthcare.

Best Scientists Citing Martin McMahon

Trending Scientists

Recently Published Articles